SCHEMBL1832

SCHEMBL1832

OCCN(CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4002211 0.96
Water SCHEMBL680919 0.96
SCHEMBL1720227 0.92
SCHEMBL28728420 0.89 MAPT (0.39)
Trolamine SCHEMBL8213273 0.88 MAPT (0.42)
Trolamine SCHEMBL15845959 0.82 MAPT (0.47)
Trolamine SCHEMBL1146 0.82 MAPT (0.47)
Trolamine SCHEMBL434089 0.82 MAPT (0.47)
Trolamine SCHEMBL4748243 0.82 MAPT (0.47)
SCHEMBL1719574 0.82 TDP1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 16453 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4684196-A1 METHODS FOR ANTIGEN RETRIEVAL OF A FIXED SAMPLE FOR MULTIPLE APPLICATIONS Resolve BioSciences GmbH (DE) 2026-01-28 EP claimed
US-20250387385-A1 TREATMENT FOR GLOMERULAR DISEASES ZYDUS LIFESCIENCES LIMITED (IN) 2025-12-25 US claimed
CN-120138073-A Bayer Wiligam oxygenase mutant and application thereof 上海合全药业股份有限公司 2025-06-13 CN claimed
EP-4565233-A1 TREATMENT FOR APLASTIC ANEMIA (AA) Zydus Lifesciences Limited (IN) 2025-06-11 EP claimed
CN-120005959-A Method for synthesizing deoxynucleoside triphosphate by enzyme method 上海合全药物研发有限公司 2025-05-16 CN claimed
EP-4539934-A1 TREATMENT FOR GLOMERULAR DISEASES Zydus Lifesciences Limited (IN) 2025-04-23 EP claimed
CN-119842830-A Preparation method of (S) -1- (2, 6-dichlorophenyl) ethanol 上海泓博尚奕药物技术有限公司 2025-04-18 CN claimed
CN-119816306-A Treatment of Aplastic Anemia (AA) 载度思生命科学有限公司 2025-04-11 CN claimed
EP-4049017-B1 APPARATUS AND METHOD FOR DETERMINATION OF BANNED SUBSTANCES TALLINN UNIV OF TECHNOLOGY (EE) 2025-03-26 EP claimed
EP-4522114-A1 A LYOPHILIZED RNA COMPOSITION eTheRNA immunotherapies NV (BE) 2025-03-19 EP claimed
US-4396597-A Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer NYEGAARD & CO. A/S (NO) 1983-08-02 US claimed
US-4390517-A WATER-SOLUBLE PRIMARY, SECONDARY, OR TERTIARY AMINES AS STABILIZERS; DIAGNOSIS/MEDICAL/; STORAGE STABILITY NEW ENGLAND NUCLEAR CORPORATION (US) 1983-06-28 US claimed
EP-0005649-B1 WATER-BASED COATING COMPOSITIONS AND COATING PROCESSES USING THEM COURTAULDS PLC (GB) 1982-05-19 EP claimed
US-4278654-A Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer NYEGAARD & CO. A/S (NO) 1981-07-14 US claimed
US-4264656-A COMPRISING A RESIN HAVING FREE CARBOYL GROUPS, A TERTIARY CARBINAMINE; CURING COURTAULDS LIMITED (GB) 1981-04-28 US claimed
US-4205072-A 3-Carbamoyloxymethyl-7-(amino-4-thiazolyl-acetamido)-cephalosporanic acid derivatives ROUSSEL UCLAF (FR) 1980-05-27 US claimed
EP-0005649-A2 Water-based coating compositions and coating processes using them COURTAULDS PLC (GB) 1979-11-28 EP claimed
US-4133889-A ANAPHYLAXIS ANTAGONISTS FISONS, LTD. (GB) 1979-01-09 US claimed
US-4054542-A Amine-epichlorohydrin polymeric compositions BUCKMAN LABORATORIES, INC. (US) 1977-10-18 US claimed
US-3996162-A INORGANIC CRYSTALLINE LATTICE MATERIAL NUCLEAR MEDICAL LABORATORIES, INC. (US) 1976-12-07 US claimed